Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Breast cancer
Closed
Phase 3
This trial is looking at 2 different chemotherapy drugs for breast cancer that doesn’t have receptors for oestrogen, progesterone or HER2. This type of breast cancer is called triple negative breast cancer. Women can also take part if they have advanced breast cancer and have a known gene fault called a BRCA gene mutation, whether or not they have any of the receptors. This trial is supported by Cancer Research UK.
Recruitment start: 16 January 2008
Recruitment end: 28 February 2014
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Prof Andrew Tutt
Breakthrough Breast Cancer
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
Institute of Cancer Research (ICR)
King's College London
NIHR Clinical Research Network: Cancer
This is Cancer Research UK trial number CRUK/07/012.
Last reviewed: 28 February 2014
CRUK internal database number: 818
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
